High sensitivity and specificity of the C6-peptide ELISA on cerebrospinal fluid in Lyme neuroborreliosis patients
Open Access
- 1 October 2011
- journal article
- research article
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 17 (10) , 1495-1500
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Effect ofBorrelia burgdorferiGenotype on the Sensitivity of C6 and 2‐Tier Testing in North American Patients with Culture‐Confirmed Lyme DiseaseClinical Infectious Diseases, 2008
- Prospective Study of Serologic Tests for Lyme DiseaseClinical Infectious Diseases, 2008
- Improved Laboratory Diagnostics of Lyme Neuroborreliosis in Children by Detection of Antibodies to New Antigens in Cerebrospinal FluidThe Pediatric Infectious Disease Journal, 2008
- C6‐peptide serology as diagnostic tool in neuroborreliosisAPMIS, 2008
- Relevance of the antibody index to diagnose Lyme neuroborreliosis among seropositive patientsNeurology, 2007
- Lyme meningoradiculitis: prospective evaluation of biological diagnosis methodsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2007
- Sensitivity and specificity of a commercial C6 peptide enzyme immuno assay in diagnosis of acute Lyme neuroborreliosisEuropean Journal of Clinical Microbiology & Infectious Diseases, 2007
- THE CLINICAL AND EPIDEMIOLOGICAL PROFILE OF LYME NEUROBORRELIOSIS IN DENMARK 1985–1990Brain, 1992
- Lyme neuroborreliosis: A new sensitive diagnostic assay for intrathecal synthesis of borrelia burgdorferi–specific immunoglobulin G, A, and MAnnals of Neurology, 1991
- Evaluation of the Intrathecal Antibody Response to Borrelia burgdorferi as a Diagnostic Test for Lyme NeuroborreliosisThe Journal of Infectious Diseases, 1990